# Granules Pharmaceuticals Inc. – FDA Inspection, Oct 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/79057046-35e3-4819-a9ee-41f1232ca884
Source feed: FDA_Inspections

> FDA inspection 1069969 of Granules Pharmaceuticals Inc., October 26, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069969
- Company Name: Granules Pharmaceuticals Inc.
- Inspection Date: 2018-10-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1311002 - 2026-04-03](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/920e888f-8fba-4596-ac5e-b8a55ca5eb4f)
- [FDA Inspection 1274604 - 2025-06-27](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/c26a7eea-057c-452e-9446-c4409110a57b)
- [FDA Inspection 1225087 - 2023-12-15](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/45371d19-7a67-4bab-ae38-48217349ea87)
- FDA Inspection 1215034 - 2023-08-03
- [FDA Inspection 1175097 - 2022-07-22](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/d7966f15-715b-4405-88ac-c9e7d0d9e64c)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcus-a-ray/d394d757-5569-4697-bec1-c24113e29d6f)
- [Company Rep](https://www.keypedia.com/people/zhao-wang/51081e23-1891-4c93-9488-f578511e0a0e)
- [Zhong Li](https://www.keypedia.com/people/zhong-li/18545b20-7fa5-4850-9dd4-cffb40c41f8d)

Company: https://www.keypedia.com/companies/granules-pharmaceuticals-inc/fa93bf3f-822e-47be-9e47-59b1c5446629

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa